Drawing on insights from a roundtable of industry leaders convened by Klick at the recent MAPS conference, let’s look at how viewing the KOL holistically can lead to new avenues of engagement and more multifaceted relationships.
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.
From the choice of where to publish to the assessment of impact, every decision holds weight in medical research publication. And yet, the metrics that have been traditionally used to guide these decisions offer only a partial view. The result: a hit-or-miss situation when it comes to reaching the target audience—healthcare professionals (HCPs) and patients. Can a data-driven approach that incorporates both traditional and the newer alternative metrics hold the key to improved publication planning, impact and thereby better patient outcomes?
The more the industry evolves, the more compliance teams need to keep pace with this change. The good news is there are 6 actionable steps you can make to stay ahead of the dynamic pressure.
Omnichannel communication is the strategy of integrating various communication channels, both digital and non-digital, and joining multiple communication touchpoints to provide a seamless, personalized experience, and unified identity across all channels, devices, and touchpoints: the customer (namely HCPs and patients), rather than the product, is at the center.
Download the new Dimensions White Paper to discover the current and emerging research trends in Pharma.
This White Paper ranks social media platforms, demonstrates how life science companies are adapting to the digital world, defines the digital opinion leader and how to find one, and provides 4 key takeaways that you can start implementing right away.
Thank you MAPS Partner Circle members for sharing use cases that bring to life MAPS’ Vision for Generative Artificial Intelligence in Medical Affairs.
This article summarizes CRA’s roundtable discussion with Medical Affairs leaders in Lisbon, which focused on transitioning Medical Affairs to a function that is co-leading strategically the clinical development and commercialization efforts.
In this Within3 White Paper, learn how your team can work toward operational excellence for Medical Affairs, despite ever-shifting roles.